Abstract
Overview
Introduction
This analysis examines the historical and forecast performance for Servier in
the ethical pharmaceutical sector. The profile encompasses global company
strategy, portfolio and pipeline analysis and assessment of financial
performance, with 1-6 year sales forecasts for key drugs. An interactive
forecasting and analysis tool provides continually updated quantitative and
qualitative information.
Reasons to Purchase
- Benchmark Servier' s performance against key rivals in the ethical
pharmaceutical sector
- See how Servier' s outlook will be shaped primarily by the launch of
generic copies of its largest product, Coversyl, in 2007
- Evaluate Servier' s strategy of expanding globally, gaining a significant
presence in emerging markets
View Cart
